CCL19 and hepatocellular carcinoma: Moreover, studies have shown that CAR-T cells engineered to co-secrete IL-7 and CCL19 (7 × 19 CAR-T cells) exhibit superior tumor suppression, proliferation capacity, and tumor infiltration in HCC xenograft models[126].